Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
DMAA
DRUGS MADE IN AMERICA ACQUISITION CORP. ORDINARY SHARES
NASDAQ
$10.84
▼ DOWN 0.46% (-0.05)

KEY STATISTICS

Market Cap$263.16 M
52w High$10.89
52w Low$10.26
Dividend Yield—
Frequency—
P/E58.28
Volume38.86K
Shares Out.24.28M

COMPANY

LEADERSHIP

Roger Bendelac
CHIEF EXECUTIVE
Roger Bendelac

ABOUT

SECTOR
Financial Services
WENT PUBLIC
January 27, 2025
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
2

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
SPAQ
4.10%
45.4K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
62.96%
HOLDERS
46
TOP 8 OF 46 · RANKED BY POSITION SIZE
Karpus Management, Inc.
2.5M sh
$26.16M
First Trust Capital Management L.P.
2.2M sh
$23.26M
Mizuho Securities Usa LLC
2.0M sh
$20.9M
Polar Asset Management Partners Inc.
1.9M sh
$19.51M
Glazer Capital, LLC
1.8M sh
$18.71M
Westchester Capital Management, LLC
1.7M sh
$17.52M
Wolverine Asset Management LLC
1.6M sh
$16.31M
Hudson Bay Capital Management LP
1.6M sh
$16.07M

PRICE

$10.84 ▼ DOWN 0.46% (−$0.05)
$10.83$10.85$10.889:30 AM10:33 AM11:37 AM12:40 PM1:43 PM2:47 PM3:50 PM10.84

About Drugs Made In America Acquisition Corp. Ordinary Shares

https://dmaacorp.com ↗

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

INDUSTRY

Shell Companies

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity3
Return On Assets5
Debt To Equity2
Price To Earnings1
Price To Book2
Overall Score2

SECTORS PEERS

PEERPRICE
TACO$10.45COMPARE
ALF$10.83COMPARE
TACOU$10.95COMPARE
TACH$10.54COMPARE
OYSE$10.40COMPARE
SIMA$11.46COMPARE
RTAC$10.43COMPARE